ARTICLE | Clinical News
SCIB1 regulatory update
February 17, 2014 8:00 AM UTC
Scancell said FDA granted Orphan Drug designation to SCIB1 to treat metastatic melanoma. In December, Scancell reported data from 14 patients with stage III/IV melanoma in the Phase II portion of an o...